Population differences in allele frequencies at the OLR1 locus may suggest geographic disparities in cardiovascular risk events

Annals of Human Biology

Volumn 37, Issue 2, 2010, Pages 137-149

  Predazzi, Irene M ^a   Martínez Labarga, Cristina ^a   Vecchione, Lucia ^a   Mango, Ruggiero ^b   Ciccacci, Cinzia ^a   Amati, Francesca ^a   Ottoni, Claudio ^a   Crawford, Michael H ^c   Rickards, Olga ^a   Romeo, Francesco ^a,d   Novelli, Giuseppe ^a,d,e  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^c UNIVERSITY OF KANSAS   (United States)

^d UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^e FATEBENEFRATELLI HOSPITAL   (Italy)

Author keywords

Cardiovascular disease; OLR1; Single nucleotide polymorphisms

Indexed keywords

ALLELE; CARDIOVASCULAR DISEASE; GENETIC MARKER; GEOGRAPHICAL VARIATION; POLYMORPHISM; POPULATION DYNAMICS; POPULATION GENETICS; PROTEIN;

EID: 77949304181     PISSN: 03014460     EISSN: 14645033     Source Type: Journal    
DOI: 10.3109/03014460903393857     Document Type: Article

References (49)

1. Allison MA, Budoff MJ, Wong ND, Blumenthal RS, Schreiner PJ, Criqui MH. 2008. Prevalence of and risk factors for subclinical cardiovascular disease in selected us Hispanic ethnic groups: The Multi-Ethnic Study of Atherosclerosis. Am J Epidemiol 167:962-969.
2. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. 1990. Basic local alignment search tool. J MoI Biol 215:403-410. (Pubitemid 20364473)
3. Aoyama T, Sawamura T, Furutani Y, Matsuoka R, Yoshida MC, Fujiwara H, Masaki T. 1999. Structure and chromosomal assignment of the human lectin-like oxidized low-density-lipoprotein receptor-1 (LOX-I) gene. Biochem J 339:177-184. (Pubitemid 29179305)
4. Biocca S, Filesi I, Mango R, Maggiore L, Baldini F, Vecchione L, Viola A, Citro G, Federici G, Romeo F, Novelli G. 2008. The splice variant LOXIN inhibits LOX-I receptor function through hetero-oligomerization. J MoI Cell Cardiol 44:561-570.
5. Biocca S, Falconi M, Filesi I, Baldini F, Vecchione L, Mango R, Romeo F, Federici G, Desideri A, Novelli G. 2009. Functional analysis and molecular dynamics simulation of LOX-I K167N polymorphisms reveal alteration of receptor activity. PloS ONE 4:2:e4648.
6. Biondi G, Rickards O, Martinez-Labarga C, Taraborelli T, Ciminelli B, Gruppioni G. 1996. Biodemography and genetics of the Berba of Benin. American Journal of Physical Anthropology 99:519-535.
7. Budowle B, Smith J, Moretti T, Di Zinno J. 2000. DNA typing protocols: Molecular biology and forensic analysis. Natick, MA: Eaton Publishing.
8. Chen XP, Du GH. 2007. Lectin-like oxidised low-density lipoprotein receptor-1: Protein, ligands, expression and pathophysiological significance. Clin Med J 120:421-426.
9. Chen Q, Reis SE, Kammerer C, Craig WY, LaPierre SE, Luedecking Zimmer E, McNamara D, Pauly DF, Sharaf B, Holubkov R, Bairey Merz CN, Sopko G, Bontempo F, Kamboh MI. 2003. Genetic variation in lectin-like oxidized low-density lipoprotein receptor 1 (LOX-I) gene and the risk of coronary artery disease. Circulation 107:3146-3151. (Pubitemid 36793083)
10. Dhaliwal and Steinbrecher. 1999. Scavenger receptors and oxidized low density lipoproteins. Clin Chim Acta 286:191-205.
11. Dunn S, Vohra RS, Murphy JE, Homer-Vanniasinkam S, Walker JH, Ponnambalam S. 2008. The lectin-like oxidised low-density-lipoprotein receptor: A pro-inflammatory factor in vascular disease. Biochem J 409:349-355. (Pubitemid 351184953)
12. Excoffier L, Slatkin M. 2005. Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 12:921-927.
13. Excoffier L, Smouse P, Quattro J. 1992. Analysis of molecular variance inferred from metric distances among DNA haplotypes: Application to human mitochondrial DNA restriction data. Genetics 131:479-491.
14. Giambra V, Martinez-Labarga C, Giufrè M, Modiano D, Simporè J, Gisladottir BK, Francavilla R, Zhelezova G, Kilic SS, Crawford MH, Biondi G, Rickards O, Frezza D. 2006. Immunoglobulin Enhancer HSl, 2 polymorphism: A new powerful anthropogenetic marker. Ann Hum Genet 70:1-5.
15. Giardina E, Pietrangeli I, Martinez-Labarga C, Martone C, de Angelis F, Spinella A, De Stefano G, Rickards O, Novelli G. 2008. Haplotypes in SLC24A5 Gene as ancestry informative markers in different populations. Curr Genom 9:110-114. (Pubitemid 351888528)
16. Hancock AM, Witonsky DB, Gordon AS, Eshel G, Pritchard JK, Coop G, Di Rienzo A. 2008. Adaptations to climate in candidate genes for common metabolic disorders. PloS Genet 4:e32.
17. Hattori H, Sonoda A, Sato H, Ito D, Tanahashi N, Murata M, Saito I, Watanabe K, Suzuki N. 2006. G501C polymorphism of oxidized LDL receptor gene (OLR1) and ischemic stroke. Brain Res 22:246-249.
18. Ioannidis JP, Ntzani EE, Trikalinos TA. 2004. 'Racial' differences in genetic effects of complex diseases. Nat Genet 36:1312-1318.
19. Jackson FL. 2008. Ethnogenetic layering (EL): An alternative to the traditional race model in human variation and health disparity studies. Ann Hum Biol. 35:121-144.
20. Keys A. 1970. Coronary heart disease in seven countries. Circulation 41:1-211.
21. Knowles JW, Assimes TL, Boerwinkle E, Fortmann SP, Go A, Grove ML, Hlatky M, Iribarren C, Li J, Myers R, Rish N, Sidney S, Southwick A, Volcik KA, Quertermous T. 2008. Failure to replicate an association of SNPs in the oxidized LDL receptor gene (OLR1') with CAD. BMC Med Genet 9:23. (Pubitemid 351566890)
22. Kruskal JB, Wish M. 1978. Multidimensional scaling. Beverly Hills, CA Sage.
23. Kullo IJ, Ding K. 2007. Patterns of population differentiation of candidate genes for cardiovascular disease. BMC Genet 12:8-48.
24. Lanfear DE, Marsh S, Cresci S, Shannon WD, Sperms JA, McLeod HL. 2004. Genotypes associated with myocardial infarction are more common in African Americans than in European Americans. J Am Coll Cardiol 44:165-167. (Pubitemid 38968476)
25. LevyD,KannelWB.2000.Searchingforanswers- ethnicdisparitiesincardiovascularrisk.Lancet356:266-267.(Pubitemid30459579)
26. Lohmueller KE, Amit RI, Schmidt S, Boyko AR, Hernandez RD, Hubisz MJ, Sninsky JJ, White TJ, Sunyaev SR, Nielsen R, Clark AG, Bustamante CD. 2008. Proportionally more deleterious genetic variation in European than in African populations. Nature 451:994-998. (Pubitemid 351301732)
27. Mango R, Biocca S, del Vecchio F, Clementi F, Sangiuolo F, Amati F, Filareto A, Grelli S, Spitalieri P, Filesi I, Favalli C, Lauro R, Mehta JH, Romeo F, Novelli G. 2005. In vivo and in vitro studies support that a new splicing isoform is protective against acute myocardial infarction. Circ Res 97:152-158.
28. MangoR,ClementiF,BorgianiP,ForleoGB,FedericiM,ContinoG,GiardinaE,GarzaL, FahdiIE,LauroR,MehtaJL,NovelliG,RomeoF.2003. AssociationofsinglenucleotidepolymorphismsintheoxidisedLDLreceptor1(OLR1) geneinpatientswithacutemyocardialinfarction.JMedGenet40:933-936. (Pubitemid38117545)
29. Martinez-Labarga C, Lelli R, Tarsi T, Babalini C, De Angelis F, Ottoni C, Giambra V, Pepe G, Azzebi E, Frezza D, Biondi G, Rickards O. 2007. Polymorphisms of the COL1A2, CYPlAl and HS1,2 Ig enhancer genes in the Tuaregs from Libya. Ann Hum Biol 34:425-436. (Pubitemid 47057149)
30. Miller SA, Dykes DD, Polesky HF. 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215.
31. Muoio DM, Newgard CB. 2008. Mechanisms of disease: Molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes. Nat Rev Mol Cell Biol. 9:193-205.
32. Novelli G, Borgiani P, Mango R, Lauro R, Romeo F. 2006a. Further evidence that polymorphisms of the OLR1 gene are associated with susceptibility to coronary artery disease and myocardial infarction. Nutr Metab Cardiovasc Dis 17:e7-8. (Pubitemid 46400418)
33. Novelli G, Borgiani P, Mango R, Romeo F, Mehta JL. 2006b. OLR1 gene and coronary artery disease/acute myocardial infarction: Replication in an independently collected sample. Eur J Hum Genet 14:127-130.
34. OhmoriR,MomiyamaY,NaganoM,TaniguchiH,EgashiraT,YonemuraA,NakamuraH, KondoK,OhsuzuF.2004.Anoxidizedlow- densitylipoproteinreceptorgenevariantisinverselyassociatedwiththeseverityofcoro naryarterydisease.ClinCardiol27:641-644.(Pubitemid39441747)
35. Park H, Adsit FG, Boyington , JC. 2005. The 1.4 angstrom crystal structure of the human oxidised low density lipoprotein receptor lox-1. J Biol Chem 280:13593-13599 (Pubitemid 40517252)
36. ReynoldsJ,WeirBS,CockerhamCC.1983.Estimationofthecoancestrycoefficient: Basisforashort-termgeneticdistance.Genetics105:767-779.(Pubitemid14246280)
37. Rish N, Burchard E, Ziv E, Tang H. 2002. Categorization of humans in biomedical research: Gene, race and disease. Genom Biol 3:7.
38. Romeo S, Pennacchio LA, Fu Y, Boerwinkle E, Tybjaerg-Hansen A, Hobbs HH, Cohen JC. 2007. Populationbased resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL. Nat Genet 39:513-516. (Pubitemid 46514768)
39. Sawamura T, Kume N, Aoyama T, Moriwaki H, Hoshikawa H, Aiba Y, Tanaka T, Miwa S, Katsura Y, Kita T, Masaki T. 1997. An endothelial receptor for oxidized low-density lipoprotein. Nature 386:73-77. (Pubitemid 27130922)
40. Schneider S, Roessli D, Excoffier L. 2000. Arlequin: A software for population genetics data analysis. User manual ver 2.000. Genetics and Biometry Laboratory, Department of Anthropology, University of Geneva, Geneva.
41. Sentinelli F, Filippi E, Fallarino M, Romeo S, Fanelli M, Buzzetti R, Berni A, Baroni MG. 2006. The 3'-UTR C>T polymorphism of the oxidized LDL-receptor 1 (OLR1) gene does not associate with coronary artery disease in Italian CAD patients or with the severity of coronary disease. Nutr Metab Cardiovasc Dis 16:345-352.
42. Shiffman D, O'Meara ES, Bare LA, Rowland CM, Louie JZ, Arellano AR, Lumley T, Rice K, Iakoubova O, Luke MM, Young BA, Malloy MJ, Kane JP, Ellis SG, Tracy RP, Devlin JJ, Psaty BM. 2008. Association of gene variants with incident myocardial infarction in the Cardiovascular Health Study. Arterioscler Thromb Vase Biol 28:173-179.
43. Stephens M, Donnelly P. 2003. A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 73:1162-1169. (Pubitemid 37414228)
44. Stephens M, Scheet P. 2005. Accounting for decay of linkage disequilibrium in haplotype inference and missingdata imputation. Am J Hum Genet 76:449-462. (Pubitemid 40250525)
45. Stephens M, Smith NJ, Donnelly P. 2001. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68:978-989. (Pubitemid 32289743)
46. Tatsuguchi M, Furutani M, Hinagata J, Tanaka T, Furutani Y, Imamura S, Kawana M, Masaki T, Kasanuki H, Sawamura T, Matsuoka R. 2003. Oxidized LDL receptor gene (OLR1) is associated with the risk of myocardial infarction. Biochem Biophys Res Commun 28:247-250.
47. The International HapMap Consortium. 2005. A haplotype map of the human genome. Nature 437:1299-1320.
48. Yamanaka S, Zhang XY, Miura K, Kim S, Iwao H. 1998. The human gene encoding the lectin-type oxidized LDL receptor (OLR1) is a novel member of the natural killer gene complex with a unique expression profile. Genomics 54:191-199.
49. Verra F, Mangano VD, Modiano D. 2009. Genetics of susceptibility to Plasmodium falciparum: From classical malaria resistance genes towards genome-wide association studies. Parasite Immunol 31:234-253.